Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
Michele Zanoni1, Henrique Borges da Silva2, Elena Adinolfi3
1Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
Frontiers in Oncology
|November 29, 2023
Abstract
No abstract available in PubMed .
Keywords:
cancermetabolismmetastasispurinergic signalingresistance to therapystemnesstumor microenvironmentMore Related Videos
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.5K
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.6K
